Prostate Cancer - Results from #24500

Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens - Abstract November 1, 2012

Age and comorbidity in early prostate cancer - Abstract November 1, 2012

Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate - Abstract November 1, 2012

Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer - Abstract November 1, 2012

Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer - Abstract November 1, 2012

Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: A systematic review - Abstract November 1, 2012

Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score - Abstract November 1, 2012

BJUI Mini Reviews - Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel October 31, 2012

Peg-filgrastim and cabazitaxel in prostate cancer patients - Abstract October 31, 2012

TMPRSS2-ERG fusion transcripts in matched urine and needle rinse material after biopsy for the detection of prostate cancer - Abstract October 31, 2012

Who benefits from a psychosocial counselling versus educational intervention to improve psychological quality of life in prostate cancer survivors? - Abstract October 31, 2012

Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma - Abstract October 31, 2012

Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): Lack of utility to stratify cancer risks associated with HGPIN - Abstract October 31, 2012

The national burden of infections after prostate biopsy in England and Wales: A wake-up call for better prevention - Abstract October 31, 2012

Management of bone metastases in refractory prostate cancer - role of denosumab - Abstract October 31, 2012

Prostate cancer screening practices of African-American and non-African-American US primary care physicians: A cross-sectional survey - Abstract October 31, 2012

Statin use and risk of prostate cancer: A meta-analysis of observational studies - Abstract October 31, 2012

Prostate segmentation by sparse representation based classification - Abstract October 30, 2012

A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer - Abstract October 30, 2012

A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: The Cancer and Osteoporosis Research with Alendronate and Leupr October 30, 2012

Page 1226 of 1436